Quick Answer
GUIDED THERAPEUTICS INC reported Stockholders Equity of -$6.01 million for fiscal year 2025.
GUIDED THERAPEUTICS INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$6.01M | -22.8% |
| 2024 | -$4.89M | -28.5% |
| 2023 | -$3.81M | -32.0% |
| 2022 | -$2.88M | +47.1% |
| 2021 | -$5.45M | +49.8% |
| 2020 | -$10.86M | +35.9% |
| 2019 | -$16.93M | -7.0% |
| 2018 | -$15.82M | +18.4% |
| 2017 | -$19.40M | -109.4% |
| 2016 | -$9.27M | -66.6% |
| 2015 | -$5.56M | -24.6% |
| 2014 | -$4.46M | -4072.9% |
| 2013 | -$107.0K | -109.4% |
| 2012 | $1.13M | -28.2% |
| 2011 | $1.58M | +55.7% |
| 2010 | $1.01M | +108.5% |
| 2009 | -$11.97M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$5.65M | -14.8% | -3.2% |
| June 30, 2025 | -$5.47M | -17.2% | -8.8% |
| March 31, 2025 | -$5.03M | -25.3% | -2.8% |
| December 31, 2024 | -$4.89M | -28.5% | +0.6% |
| September 30, 2024 | -$4.92M | -34.7% | -5.4% |
| June 30, 2024 | -$4.67M | -40.8% | -16.3% |
| March 31, 2024 | -$4.01M | -40.5% | -5.4% |
| December 31, 2023 | -$3.81M | -32.0% | -4.3% |
- GUIDED THERAPEUTICS INC showed a decrease of -22.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2025 period, GUIDED THERAPEUTICS INC’s stockholders equity has grown by 49.8% (from -$11.97 million to -$6.01 million).
- The most recent figure is from GUIDED THERAPEUTICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: